Point72 Asset Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History
Bought
Maintained
Sold
Other funds holding MTACU
MF
HP
DM
DCP
IM
MP
PVI
VI
MA
Point72 Asset Management's MTACU Position: Q1 2021 in Review
Point72 Asset Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2021, closing a stake of 600,000 shares — an estimated $6.3M sold.
Point72 Asset Management first reported a position in MTACU in Q4 2020 and held it in 1 quarter. The position peaked at $6.3M in Q4 2020. 31 funds tracked by Wall St. Rank hold MTACU as of Q1 2021.
- Point72 Asset Management reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
- Point72 Asset Management sold 600,000 MedTech Acquisition Corporation Unit shares in Q1 2021, an estimated $6.3M.
- Point72 Asset Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
- Point72 Asset Management's MedTech Acquisition Corporation Unit position peaked at $6.3M in Q4 2020.
- 31 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2021.
Based on Point72 Asset Management's 13F filing for Q1 2021, filed 17 May 2021.